210 related articles for article (PubMed ID: 34854112)
1. Metronidazole gel (0.75%) in Japanese patients with rosacea: A randomized, vehicle-controlled, phase 3 study.
Miyachi Y; Yamasaki K; Fujita T; Fujii C
J Dermatol; 2022 Mar; 49(3):330-340. PubMed ID: 34854112
[TBL] [Abstract][Full Text] [Related]
2. A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial.
Elewski BE; Fleischer AB; Pariser DM
Arch Dermatol; 2003 Nov; 139(11):1444-50. PubMed ID: 14623704
[TBL] [Abstract][Full Text] [Related]
3. Topical metronidazole maintains remissions of rosacea.
Dahl MV; Katz HI; Krueger GG; Millikan LE; Odom RB; Parker F; Wolf JE; Aly R; Bayles C; Reusser B; Weidner M; Coleman E; Patrignelli R; Tuley MR; Baker MO; Herndon JH; Czernielewski JM
Arch Dermatol; 1998 Jun; 134(6):679-83. PubMed ID: 9645635
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of two randomized, double-blind, and vehicle-controlled pivotal studies.
Fowler J; Jackson M; Moore A; Jarratt M; Jones T; Meadows K; Steinhoff M; Rudisill D; Leoni M
J Drugs Dermatol; 2013 Jun; 12(6):650-6. PubMed ID: 23839181
[TBL] [Abstract][Full Text] [Related]
5. Once-daily topical metronidazole cream formulations in the treatment of the papules and pustules of rosacea.
Dahl MV; Jarratt M; Kaplan D; Tuley MR; Baker MD
J Am Acad Dermatol; 2001 Nov; 45(5):723-30. PubMed ID: 11606923
[TBL] [Abstract][Full Text] [Related]
6. A multicentre, randomized, double-masked, parallel group, vehicle-controlled phase IIb study to evaluate the safety and efficacy of 1% and 3% topical minocycline gel in patients with papulopustular rosacea.
Webster G; Draelos ZD; Graber E; Lee MS; Dhawan S; Salman M; Magrath GN
Br J Dermatol; 2020 Sep; 183(3):471-479. PubMed ID: 31907924
[TBL] [Abstract][Full Text] [Related]
7. A Phase II, Randomized, Double-Blind Clinical Study Evaluating the Safety, Tolerability, and Efficacy of a Topical Minocycline Foam, FMX103, for the Treatment of Facial Papulopustular Rosacea.
Mrowietz U; Kedem TH; Keynan R; Eini M; Tamarkin D; Rom D; Shirvan M
Am J Clin Dermatol; 2018 Jun; 19(3):427-436. PubMed ID: 29396702
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of azelaic acid (15%) gel as a new treatment for papulopustular rosacea: results from two vehicle-controlled, randomized phase III studies.
Thiboutot D; Thieroff-Ekerdt R; Graupe K
J Am Acad Dermatol; 2003 Jun; 48(6):836-45. PubMed ID: 12789172
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of once-daily metronidazole 1% gel compared with twice-daily azelaic acid 15% gel in the treatment of rosacea.
Wolf JE; Kerrouche N; Arsonnaud S
Cutis; 2006 Apr; 77(4 Suppl):3-11. PubMed ID: 16706244
[TBL] [Abstract][Full Text] [Related]
10. Adapalene vs. metronidazole gel for the treatment of rosacea.
Altinyazar HC; Koca R; Tekin NS; Eştürk E
Int J Dermatol; 2005 Mar; 44(3):252-5. PubMed ID: 15807740
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of a novel rosacea treatment system: an investigator-blind, randomized, parallel-group study.
Leyden JJ
J Drugs Dermatol; 2011 Oct; 10(10):1179-85. PubMed ID: 21968669
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of ivermectin 1% cream in treatment of papulopustular rosacea: results of two randomized, double-blind, vehicle-controlled pivotal studies.
Stein L; Kircik L; Fowler J; Tan J; Draelos Z; Fleischer A; Appell M; Steinhoff M; Lynde C; Liu H; Jacovella J
J Drugs Dermatol; 2014 Mar; 13(3):316-23. PubMed ID: 24595578
[TBL] [Abstract][Full Text] [Related]
13. A comparison of topical azelaic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea.
Maddin S
J Am Acad Dermatol; 1999 Jun; 40(6 Pt 1):961-5. PubMed ID: 10365928
[TBL] [Abstract][Full Text] [Related]
14. Topical metronidazole therapy for rosacea.
Bleicher PA; Charles JH; Sober AJ
Arch Dermatol; 1987 May; 123(5):609-14. PubMed ID: 2953312
[TBL] [Abstract][Full Text] [Related]
15. A double-blind, multicenter clinical trial comparing efficacy of once-daily metronidazole 1 percent cream to vehicle in patients with rosacea.
Breneman DL; Stewart D; Hevia O; Hino PD; Drake LA
Cutis; 1998 Jan; 61(1):44-7. PubMed ID: 9466083
[TBL] [Abstract][Full Text] [Related]
16. The appearance of facial foundation cosmetics applied after metronidazole gel 1%.
Draelos ZD; Colón LE; Preston N; Johnson LA; Gottschalk RW
Cutis; 2011 May; 87(5):251-9. PubMed ID: 21699130
[TBL] [Abstract][Full Text] [Related]
17. Improvement in facial erythema within 30 minutes of initial application of brimonidine tartrate in patients with rosacea.
Jackson JM; Fowler J; Moore A; Jarratt M; Jones T; Meadows K; Steinhoff M; Rudisill D; Leoni M;
J Drugs Dermatol; 2014 Jun; 13(6):699-704. PubMed ID: 24918560
[TBL] [Abstract][Full Text] [Related]
18. A multicenter study of topical azelaic acid 15% gel in combination with oral doxycycline as initial therapy and azelaic acid 15% gel as maintenance monotherapy.
Thiboutot DM; Fleischer AB; Del Rosso JQ; Rich P
J Drugs Dermatol; 2009 Jul; 8(7):639-48. PubMed ID: 19588640
[TBL] [Abstract][Full Text] [Related]
19. A look at the safety of metronidazole 1% gel: cumulative irritation, contact sensitization, phototoxicity, and photoallergy potential.
Beutner KR; Lemke S; Calvarese B
Cutis; 2006 Apr; 77(4 Suppl):12-7. PubMed ID: 16706245
[TBL] [Abstract][Full Text] [Related]
20. Double-blind, randomized, vehicle-controlled clinical trial of once-daily benzoyl peroxide/clindamycin topical gel in the treatment of patients with moderate to severe rosacea.
Breneman D; Savin R; VandePol C; Vamvakias G; Levy S; Leyden J
Int J Dermatol; 2004 May; 43(5):381-7. PubMed ID: 15117375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
